Observational Study of Durvalumab in Patients With Non-small-cell Lung Cancer in the United Kingdom
Clinical trial NCT04667312 · COMPLETED
Trial details
- NCT number
- NCT04667312
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-06-24
- Primary completion
- 2022-09-28
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.